Flower City Capital IMRX — IMMUNEERING CORP

Ownership history in Flower City Capital  ·  4 quarters on record

AI Ownership Summary

Flower City Capital reported IMMUNEERING CORP (IMRX) in 4 quarterly 13F filings from 2025 Q2 through 2026 Q1. Peak portfolio weight reached 0.15% in 2026 Q1. The latest visible filing shows IMRX at 0.15% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this IMRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Flower City Capital's position in IMMUNEERING CORP, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

IMRX was reported at 0.15% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.15% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

IMRX stock page Flower City Capital fund profile Flower City Capital full holdings
How Flower City Capital held IMRX — position size vs. price
% of Fund (quarterly)    IMRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED — — — 55,029 +12,800 +30.3% 0.15% $290K 2026-04-14 $5.41
2025 Q4 ADDED — — — 42,229 +13,000 +44.5% 0.14% $278K 2026-01-22 $5.34
2025 Q3 REDUCED 8.7% -4.9% ✅ 29,229 -2,800 -8.7% 0.11% $205K 2025-10-08 $6.50
2025 Q2 INITIATED — — — 32,029 — — 0.06% $108K 2025-07-16 $3.96

🏢 Other funds also holding IMRX

As of 2026 Q1 — sorted by position size

Sanofi 4.25% Occam Crest Management LP 1.74% Diametric Capital, LP 3Y 7Y 0.24% DCF Advisers, LLC 3Y 0.2% Prosight Management, LP 3Y 7Y 0.11% Burkehill Global Management, LP 0.08% Kelsey Financial, LLC 0.07% Future Financial Wealth Managment LLC 3Y 0.07% ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 0.06% FNY Investment Advisers, LLC 3Y 7Y 0.05%

FAQ About Flower City Capital and IMRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Flower City Capital reported owning IMRX?

Flower City Capital reported IMRX across 4 quarterly 13F filings, from 2025 Q2 through 2026 Q1.

What was the largest reported IMRX position in Flower City Capital's portfolio?

The largest reported portfolio weight for IMRX was 0.15% in 2026 Q1.

What is the latest reported IMRX position on this page?

The most recent filing on this page is 2026 Q1, when Flower City Capital reported 55,029 shares, equal to 0.15% of portfolio, with an estimated market value of $290K.

What does the chart on this IMRX ownership page compare?

The chart compares Flower City Capital's quarterly IMRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Flower City Capital time their IMRX position?

Based on 13F filing dates vs. subsequent IMRX price moves, Flower City Capital correctly timed 3 out of 3 reported position changes (100%). The annualised alpha on IMRX relative to SPY over the holding period was +30.3%.

← Back to Flower City Capital Holdings